These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 10400739

  • 1. Human immunodeficiency virus type 1 strains R5 and X4 induce different pathogenic effects in hu-PBL-SCID mice, depending on the state of activation/differentiation of human target cells at the time of primary infection.
    Fais S, Lapenta C, Santini SM, Spada M, Parlato S, Logozzi M, Rizza P, Belardelli F.
    J Virol; 1999 Aug; 73(8):6453-9. PubMed ID: 10400739
    [Abstract] [Full Text] [Related]

  • 2. T-cell dysfunctions in hu-PBL-SCID mice infected with human immunodeficiency virus (HIV) shortly after reconstitution: in vivo effects of HIV on highly activated human immune cells.
    Rizza P, Santini SM, Logozzi MA, Lapenta C, Sestili P, Gherardi G, Lande R, Spada M, Parlato S, Belardelli F, Fais S.
    J Virol; 1996 Nov; 70(11):7958-64. PubMed ID: 8892919
    [Abstract] [Full Text] [Related]

  • 3. Glycosylphosphatidylinositol-Anchored Anti-HIV scFv Efficiently Protects CD4 T Cells from HIV-1 Infection and Deletion in hu-PBL Mice.
    Ye C, Wang W, Cheng L, Li G, Wen M, Wang Q, Zhang Q, Li D, Zhou P, Su L.
    J Virol; 2017 Feb 01; 91(3):. PubMed ID: 27881659
    [Abstract] [Full Text] [Related]

  • 4. Differential effects of R5 and X4 human immunodeficiency virus type 1 infection on CD4+ cell proliferation and activation.
    Locher CP, Witt SA, Kassel R, Dowell NL, Fujimura S, Levy JA.
    J Gen Virol; 2005 Apr 01; 86(Pt 4):1171-1179. PubMed ID: 15784911
    [Abstract] [Full Text] [Related]

  • 5. HIV-1 infection and CD4 T cell depletion in the humanized Rag2-/-gamma c-/- (RAG-hu) mouse model.
    Berges BK, Wheat WH, Palmer BE, Connick E, Akkina R.
    Retrovirology; 2006 Nov 01; 3():76. PubMed ID: 17078891
    [Abstract] [Full Text] [Related]

  • 6. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
    Ho SH, Shek L, Gettie A, Blanchard J, Cheng-Mayer C.
    J Virol; 2005 Oct 01; 79(19):12296-303. PubMed ID: 16160156
    [Abstract] [Full Text] [Related]

  • 7. Pathogenesis of primary R5 human immunodeficiency virus type 1 clones in SCID-hu mice.
    Scoggins RM, Taylor JR, Patrie J, van't Wout AB, Schuitemaker H, Camerini D.
    J Virol; 2000 Apr 01; 74(7):3205-16. PubMed ID: 10708437
    [Abstract] [Full Text] [Related]

  • 8. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
    Blanco J, Barretina J, Clotet B, Esté JA.
    J Leukoc Biol; 2004 Oct 01; 76(4):804-11. PubMed ID: 15258189
    [Abstract] [Full Text] [Related]

  • 9. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue.
    Grivel JC, Margolis LB.
    Nat Med; 1999 Mar 01; 5(3):344-6. PubMed ID: 10086394
    [Abstract] [Full Text] [Related]

  • 10. Interleukin-4-transgenic hu-PBL-SCID mice: a model for the screening of antiviral drugs and immunotherapeutic agents against X4 HIV-1 viruses.
    Okuma K, Tanaka R, Ogura T, Ito M, Kumakura S, Yanaka M, Nishizawa M, Sugiura W, Yamamoto N, Tanaka Y.
    J Infect Dis; 2008 Jan 01; 197(1):134-41. PubMed ID: 18171296
    [Abstract] [Full Text] [Related]

  • 11. Induction of protective immune responses against R5 human immunodeficiency virus type 1 (HIV-1) infection in hu-PBL-SCID mice by intrasplenic immunization with HIV-1-pulsed dendritic cells: possible involvement of a novel factor of human CD4(+) T-cell origin.
    Yoshida A, Tanaka R, Murakami T, Takahashi Y, Koyanagi Y, Nakamura M, Ito M, Yamamoto N, Tanaka Y.
    J Virol; 2003 Aug 01; 77(16):8719-28. PubMed ID: 12885891
    [Abstract] [Full Text] [Related]

  • 12. Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
    Bahr GM, Darcissac EC, Castéran N, Amiel C, Cocude C, Truong MJ, Dewulf J, Capron A, Mouton Y.
    J Virol; 2001 Aug 01; 75(15):6941-52. PubMed ID: 11435574
    [Abstract] [Full Text] [Related]

  • 13. Phenotypic and genotypic comparisons of CCR5- and CXCR4-tropic human immunodeficiency virus type 1 biological clones isolated from subtype C-infected individuals.
    Pollakis G, Abebe A, Kliphuis A, Chalaby MI, Bakker M, Mengistu Y, Brouwer M, Goudsmit J, Schuitemaker H, Paxton WA.
    J Virol; 2004 Mar 01; 78(6):2841-52. PubMed ID: 14990703
    [Abstract] [Full Text] [Related]

  • 14. Differences in molecular evolution between switch (R5 to R5X4/X4-tropic) and non-switch (R5-tropic only) HIV-1 populations during infection.
    Mild M, Kvist A, Esbjörnsson J, Karlsson I, Fenyö EM, Medstrand P.
    Infect Genet Evol; 2010 Apr 01; 10(3):356-64. PubMed ID: 19446658
    [Abstract] [Full Text] [Related]

  • 15. Envelope-dependent restriction of human immunodeficiency virus type 1 spreading in CD4(+) T lymphocytes: R5 but not X4 viruses replicate in the absence of T-cell receptor restimulation.
    Vicenzi E, Bordignon PP, Biswas P, Brambilla A, Bovolenta C, Cota M, Sinigaglia F, Poli G.
    J Virol; 1999 Sep 01; 73(9):7515-23. PubMed ID: 10438841
    [Abstract] [Full Text] [Related]

  • 16. The human HIV/peripheral blood lymphocyte (PBL)-SCID mouse. A modified human PBL-SCID model for the study of HIV pathogenesis and therapy.
    Boyle MJ, Connors M, Flanigan ME, Geiger SP, Ford H, Baseler M, Adelsberger J, Davey RT, Lane HC.
    J Immunol; 1995 Jun 15; 154(12):6612-23. PubMed ID: 7759895
    [Abstract] [Full Text] [Related]

  • 17. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A, Tanaka R, Kodama A, Yamamoto N, Ansari AA, Tanaka Y.
    Clin Dev Immunol; 2005 Dec 15; 12(4):235-42. PubMed ID: 16584108
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin.
    Nicoletti F, Lapenta C, Donati S, Spada M, Ranazzi A, Cacopardo B, Mangano K, Belardelli F, Perno C, Aquaro S.
    Clin Exp Immunol; 2009 Jan 15; 155(1):28-34. PubMed ID: 19076826
    [Abstract] [Full Text] [Related]

  • 19. HIV-1 R5 Macrophage-Tropic Envelope Glycoprotein Trimers Bind CD4 with High Affinity, while the CD4 Binding Site on Non-macrophage-tropic, T-Tropic R5 Envelopes Is Occluded.
    Quitadamo B, Peters PJ, Repik A, O'Connell O, Mou Z, Koch M, Somasundaran M, Brody R, Luzuriaga K, Wallace A, Wang S, Lu S, McCauley S, Luban J, Duenas-Decamp M, Gonzalez-Perez MP, Clapham PR.
    J Virol; 2018 Jan 15; 92(2):. PubMed ID: 29118121
    [Abstract] [Full Text] [Related]

  • 20. Humanized mice dually challenged with R5 and X4 HIV-1 show preferential R5 viremia and restricted X4 infection of CCR5(+)CD4(+) T cells.
    Terahara K, Ishige M, Ikeno S, Okada S, Kobayashi-Ishihara M, Ato M, Tsunetsugu-Yokota Y.
    Microbes Infect; 2015 May 15; 17(5):378-86. PubMed ID: 25839960
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.